These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 26590669)

  • 41. [Assessment of psychosocial functioning in multiple sclerosis: psychometric characteristics of four self-report measures].
    Haase VG; Lacerda SS; Lima Ede P; Corrêa Tde D; Brito DC; Lana-Peixoto MA
    Arq Neuropsiquiatr; 2004 Jun; 62(2A):282-90. PubMed ID: 15235732
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development of a multidimensional measure for recurrent abdominal pain in children: population-based studies in three settings.
    Malaty HM; Abudayyeh S; O'Malley KJ; Wilsey MJ; Fraley K; Gilger MA; Hollier D; Graham DY; Rabeneck L
    Pediatrics; 2005 Feb; 115(2):e210-5. PubMed ID: 15687428
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Developing a measure to assess identity reconstruction in patients with multiple sclerosis.
    Stepleman LM; Floyd RM; Valvano-Kelley A; Penwell-Waines L; Wonn S; Crethers D; Rahn R; Smith S
    Rehabil Psychol; 2017 May; 62(2):165-177. PubMed ID: 28447807
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Psychometric evaluation of the Chicago Multiscale Depression Inventory in multiple sclerosis patients.
    Chang CH; Nyenhuis DL; Cella D; Luchetta T; Dineen K; Reder AT
    Mult Scler; 2003 Mar; 9(2):160-70. PubMed ID: 12708812
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The multiple sclerosis self-concept change scale: Development and validation of a new measure.
    Emery H; van der Mei I; Padgett C; Ownsworth T; Burke T; Giles L; Honan CA
    Mult Scler Relat Disord; 2023 Nov; 79():104955. PubMed ID: 37639780
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Validation of the preference-based multiple sclerosis index.
    Kuspinar A; Mayo NE
    Mult Scler; 2019 Oct; 25(11):1496-1505. PubMed ID: 30070613
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Patient-reported outcomes in multiple sclerosis: a systematic comparison of available measures.
    Khurana V; Sharma H; Afroz N; Callan A; Medin J
    Eur J Neurol; 2017 Sep; 24(9):1099-1107. PubMed ID: 28695634
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Aphasia Communication Outcome Measure (ACOM): Dimensionality, Item Bank Calibration, and Initial Validation.
    Hula WD; Doyle PJ; Stone CA; Austermann Hula SN; Kellough S; Wambaugh JL; Ross KB; Schumacher JG; St Jacque A
    J Speech Lang Hear Res; 2015 Jun; 58(3):906-19. PubMed ID: 25812178
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development of a brief clinician-reported outcome measure of multiple sclerosis signs and symptoms: The Clinician Rating of Multiple Sclerosis (CRoMS).
    Matza LS; Stewart KD; Phillips G; Delio P; Naismith RT
    Mult Scler Relat Disord; 2019 Oct; 35():253-261. PubMed ID: 31437740
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Improving the quality of life of multiple sclerosis patients through coping strategies in routine medical practice.
    Devy R; Lehert P; Varlan E; Genty M; Edan G
    Neurol Sci; 2015 Jan; 36(1):85-90. PubMed ID: 25064233
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Examining the factor structure of the Multiple Sclerosis Impact Scale.
    Fitzgerald SM; Li J; Rumrill PD; Merchant W; Bishop M
    Work; 2014; 49(3):523-38. PubMed ID: 23823213
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Factor analyses of a social support scale using two methods.
    Yu Y; Shiu CS; Yang JP; Wang M; Simoni JM; Chen WT; Cheng J; Zhao H
    Qual Life Res; 2015 Apr; 24(4):787-94. PubMed ID: 25267103
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Distilling the essence of appraisal: a mixed methods study of people with multiple sclerosis.
    Rapkin BD; Schwartz CE
    Qual Life Res; 2016 Apr; 25(4):793-805. PubMed ID: 26342930
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Paraclinical support of the person diagnosed with multiple sclerosis.
    Vitali S
    Int MS J; 2004 Apr; 11(1):2-9. PubMed ID: 15125811
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The use of quality of life measures in multiple sclerosis research.
    Nortvedt MW; Riise T
    Mult Scler; 2003 Feb; 9(1):63-72. PubMed ID: 12617271
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Factors that contribute to quality of life outcomes prioritised by people with multiple sclerosis.
    Somerset M; Peters TJ; Sharp DJ; Campbell R
    Qual Life Res; 2003 Feb; 12(1):21-9. PubMed ID: 12625515
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Measuring Social Relationships in Different Social Systems: The Construction and Validation of the Evaluation of Social Systems (EVOS) Scale.
    Aguilar-Raab C; Grevenstein D; Schweitzer J
    PLoS One; 2015; 10(7):e0133442. PubMed ID: 26200357
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Exploratory and confirmatory factor analysis of emPHasis-10: The health-related quality-of-life measure in pulmonary hypertension.
    Rawlings GH; Gaskell C; Beail N; Thompson A; Armstrong I
    Pulm Circ; 2024 Apr; 14(2):e12378. PubMed ID: 38736895
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The underlying structure of the English Cancer Patient Experience Survey: Factor analysis to support survey reporting and design.
    Gomez-Cano M; Lyratzopoulos G; Campbell JL; N Elliott M; A Abel G
    Cancer Med; 2022 Jan; 11(1):3-20. PubMed ID: 34866346
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Emotions towards magnetic resonance imaging in people with multiple sclerosis.
    Engels K; Schiffmann I; Weierstall R; Rahn AC; Daubmann A; Pust G; Chard D; Lukas C; Scheiderbauer J; Stellmann JP; Heesen C
    Acta Neurol Scand; 2019 Jun; 139(6):497-504. PubMed ID: 30802931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.